AT7867 is a potent and oral inhibitor of AKT and p70 S6 kinase that induces pharmacodynamic changes and inhibits human tumor xenograft growth
AT7867 是一种强效口服 AKT 和 p70 S6 激酶抑制剂，可诱导药效学变化并抑制人类肿瘤异种移植生长
期刊:Molecular Cancer Therapeutics
影响因子:5.3
doi:10.1158/1535-7163.MCT-09-0986
Kyla M Grimshaw, Lisa-Jane K Hunter, Timothy A Yap, Simon P Heaton, Mike I Walton, Steven J Woodhead, Lynsey Fazal, Matthias Reule, Thomas G Davies, Lisa C Seavers, Victoria Lock, John F Lyons, Neil T Thompson, Paul Workman, Michelle D Garrett
